LLY vs HCA
By Alex · Tickerpine
Eli Lilly and Company vs HCA Healthcare, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | HCA |
|---|---|---|
| Price | $1,183.46 | $435.61 |
| Market cap | $1.06T | $94.31B |
| P/E ratio | 39.7 | 14.6 |
| ROE | 102.29% | — |
| Profit margin | 33.53% | 8.77% |
| Revenue growth | 47.70% | 8.70% |
| Dividend yield | 0.58% | 0.72% |
| Beta | 0.50 | 1.11 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs HCA in plain English
- LLY is the bigger company — about 11.2× the market cap of HCA.
- HCA is cheaper on earnings (P/E 14.6 vs 39.7).
- LLY is growing revenue faster (48% vs 9%).
- HCA has the higher dividend yield (0.72% vs 0.58%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
HCA return calculator
See what $1,000 in HCA Healthcare, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.